Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer patients stratified by homologous recombination deficiency status: results of the randomized JBCRG-22 study
{{output}}
Purpose: To investigate long-term outcomes for triple‑negative breast cancer (TNBC) patients enrolled in JBCRG-22. Methods: TNBC (cT1c-T3, cN0... ...
